Issues regarding COVID-19 in kidney transplantation in the ERA of the Omicron variant: a commentary by the ERA Descartes Working Group
Open Access
- 23 June 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 37 (10), 1824-1829
- https://doi.org/10.1093/ndt/gfac203
Abstract
The Omicron variant, which has become the dominant strain of SARS-CoV-2 worldwide, brings new challenges to preventing and controlling infection. Moreover, the widespread implementation of vaccination policies before and after transplantation, and the development of new prophylactic and treatment strategies for coronavirus disease 2019 (COVID-19) over the past 12–18 months, has raised several new issues concerning kidney transplant recipients. In this special report, the ERA working group DESCARTES (Developing Education Science and Care for Renal Transplantation in European States), addresses several questions related to everyday clinical practice concerning kidney transplant recipients and to the assessment of deceased and live kidney donors: what is the current risk of severe disease and of breakthrough infection, the optimal management of immunosuppression in kidney transplant recipients with COVID-19, the role of passive immunization and the efficacy of antiviral drugs in ambulatory patients, the management of drug-to-drug interactions, safety criteria for the use of SARS-CoV-2 positive donors, issues related to the use of T cell depleting agents as induction treatment, and current recommendations for shielding practices.Keywords
This publication has 59 references indexed in Scilit:
- Practicing With Uncertainty: Kidney Transplantation During the COVID-19 PandemicAmerican Journal of Kidney Diseases, 2021
- Early Changes in Kidney Transplant Immunosuppression Regimens During the COVID-19 PandemicTransplantation, 2021
- Organ Donation and Transplantation During the COVID-19 Pandemic: A Summary of the Spanish ExperienceTransplantation, 2020
- Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 EraKidney International Reports, 2020
- COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaborationNephrology Dialysis Transplantation, 2020
- Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic reviewEmergencias, 2020
- Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across EuropeKidney International, 2020
- Outcomes of Renal Transplant Recipients With SARS-CoV-2 Infection in the Eye of the Storm: A Comparative Study With Waitlisted PatientsTransplantation, 2020
- Ten years of donor-derived disease: A report of the disease transmission advisory committeeAmerican Journal of Transplantation, 2020
- How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinionNephrology Dialysis Transplantation, 2020